Stockreport

World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF Alzheimer's Clinical and Biomarker Outcomes Expected in Q1 2026CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), [Read more]